Merck, Pfizer link with Debiopharm to test immunotherapy combo
Merck KGaA and Pfizer have entered into a collaboration with Debiopharm International to evaluate the potential of combining their drugs to treat lung cancer.
Read More
Tag: IAPs
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
